Mycobacterium tuberculosis Flashcards
Incubation Period
2-12 weeks
General Characteristics
Slender, rod-shaped bacilli, slightly bent
non-motile, obligate aerobes, grow in clusters, do not form spores.
Has lipid-rich cell walls that are resistant to penetration by gram stain. (weakly gram positive)
Acid-fast bacilli (Ziehl-Neelsen stain)
Transmission
Respiratory droplets
Pathogenesis
1.) inhaled microbe. Alveolar macrophage will try and to kill it.
2.) due to sulfolipids, microbe will inhibit that. It will thrive instead.
3.) More macrophages infiltrate area due to multiplying bacteria.
4.) Walling it off, stopping spread of organism but not killing it.
5.) Hard outer case calcifies, forming tubercle. Death occurs inside, aka liquefaction
6.) Liquefaction occurs until tubercle ruptures and organism spreads to other parts of body.
Diagnosis
Acid-fast (positive) aka Ziehl-Nielson stain*
Gram stain (weakly positive)
Tuberculin skin test aka PPD test** Positive skin test does not mean active disease. just means past infection / vaccination.
Chest X-ray
Culture
Nucleic acid amplification test
Isolation
Grow on Lowenstein-Jensen or Middlebrook Media
Cell wall characteristics
Impervious to many chemical disinfectants, bacteriostatic agents and drying.
Viable for weeks in sputum, bedding, etc. due to clumped growth.
Virulence Factors
Wax D: Induces delayed-type hypersensitivity reaction
Cord factor (trehalose mycolate): inhibits mitochondrial respiration, inhibits neutrophil metration, causes organism to grow as “Serpentine cords” in liquid medium.
Sulfolipids (Sulfatides): Inhibit phagosome-lysosome fusion allowing organism to survive intracellularly.
Miliary TB
Occurs when microbe affects part of body other than lung.
Treatment
Isoniazid (INH) - inhibits cell wall synthesis
Rifampin - inhibits bacterial RNA polymerase
Pyrazinamide - blocks CoA synthesis
Use these three, then one of the below:
Ethambutol - inhibits ccell wall synthesis
Streptomycin - inhibits protein synthesis.
Prevention
Prophylactic Isoniazid for high risk groups (antibiotic)
BCG vaccine